These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25250015)

  • 1. O-GlcNAcylation and Metabolic Reprograming in Cancer.
    Jóźwiak P; Forma E; Bryś M; Krześlak A
    Front Endocrinol (Lausanne); 2014; 5():145. PubMed ID: 25250015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway.
    Zhang B; Zhou P; Li X; Shi Q; Li D; Ju X
    Am J Cancer Res; 2017; 7(6):1337-1349. PubMed ID: 28670495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins.
    Dehennaut V; Leprince D; Lefebvre T
    Front Endocrinol (Lausanne); 2014; 5():155. PubMed ID: 25309514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of O-GlcNAc modification in cancer epigenetics.
    Forma E; Jóźwiak P; Bryś M; Krześlak A
    Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer.
    Champattanachai V; Netsirisawan P; Chaiyawat P; Phueaouan T; Charoenwattanasatien R; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J
    Proteomics; 2013 Jul; 13(14):2088-99. PubMed ID: 23576270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation links oncogenic signals and cancer epigenetics.
    Sun L; Lv S; Song T
    Discov Oncol; 2021 Nov; 12(1):54. PubMed ID: 35201498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrient-driven O-GlcNAc cycling - think globally but act locally.
    Harwood KR; Hanover JA
    J Cell Sci; 2014 May; 127(Pt 9):1857-67. PubMed ID: 24762810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
    Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation: A New Cancer Hallmark?
    Fardini Y; Dehennaut V; Lefebvre T; Issad T
    Front Endocrinol (Lausanne); 2013; 4():99. PubMed ID: 23964270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
    Parker MP; Peterson KR; Slawson C
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
    Hanover JA; Chen W; Bond MR
    J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient regulation of gene expression by O-GlcNAcylation of chromatin.
    Hardivillé S; Hart GW
    Curr Opin Chem Biol; 2016 Aug; 33():88-94. PubMed ID: 27322399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.